Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils

Journal of Experimental Medicine

Volumn 184, Issue 2, 1996, Pages 429-440

  Liles, W Conrad ^a   Kiener, Peter A ^b   Ledbetter, Jeffrey A ^b   Aruffo, Alejandro ^b   Klebanoff, Seymour J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FAS ANTIGEN; GAMMA INTERFERON; GENISTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERBIMYCIN A; LIGAND; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DEATH; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NEUTROPHIL; PHAGOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029788696     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.2.429     Document Type: Article

References (60)

1. Cohen, J.J. 1991. Programmed cell death in the immune system. Adv. Immunol. 50:55-85.
2. Sun, D.Y., S. Jiang, L. Zheng, D.M. Ojcius and J.D. Young. 1994. Separate metabolic pathways leading to DNA fragmentation and apoptotic chromatin condensation. J. Exp. Med. 179:559-568.
3. Nakajima, H., P. Golstein, and P.A. Henkart. 1995. The target cell nucleus is not required for cell-mediated granzyme-or Fas-based cytotoxicity. J. Exp. Med. 181:1905-1909.
4. Lagasse, E., and I.L. Weissman. 1994. Bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J. Exp. Med. 179:1047-1052.
5. Mower, D.A., D.W. Peckham, V.A. Illera, J.K. Fishbaugh, L.L. Stunz, and R.F. Ashman. 1994. Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis. J. Immunol. 152: 4832-4842.
6. Colotta, F., F. Re, N. Polentarutti, S. Sozzani, and A. Mantovani. 1992. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 80:2012-2020.
7. Brach, M.A., S. deVos, H.-J. Gruss, and F. Herrmann. 1992. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood. 80:2920-2924.
8. Dransfield, I., S.C. Stocks, and C. Haslett. 1995. Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis. Blood. 85:3264-3273.
9. Cox, G. 1995. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J. Immunol. 154:4719-4725.
10. Liles, W.C., D.C. Dale, and S.J. Klebanoff. 1995. Glucocorticoids inhibit apoptosis in human neutrophila. Blood. 86: 3181-3188.
11. Homburg, C.H.E., M. de Haas, A.E.G.Kr. von dem Borne, A.J. Verhoeven, C.P.M. Reutelingsperger, and D. Roos. 1995. Human neutrophils lose their surface FcγRIII and acquire annexin V binding sites during apoptosis in vitro. Blood. 85:532-540.
12. Liles, W.C., and S.J. Klebanoff. 1995. Regulation of apoptosis in neutrophils - Fas track to death? J. Immunol. 55:3289-3291.
13. Managan, D.F., and S.M. Wahl. 1991. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J. Immunol. 147:3408-3412.
14. Stern, M., L. Meagher, J. Savill, and C. Haslett. 1992. Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J. Immunol. 148:3543-3549.
15. Alam, R., P. Forsythe, S. Stafford, and Y. Fukuda. 1994. Transforming growth factor β abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J. Exp. Med. 179:1041-1045.
16. Iwai, K., T. Miyawaki, T. Takizawa, A. Konno, K. Ohta, A. Yachie, H. Seki, and N. Taniguchi. 1994. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood. 84:1201-1208.
17. Pericle, F., J.H. Liu, J.I. Diaz, D.K. Blanchard, S. Wei, G. Forni, and J.Y. Djeu. 1994. Interleukin-2 prevention of apoptosis in human neutrophils. Eur. J. Immunol. 24:440-444.
18. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:233-243.
19. Nagata, S. 1994. Fas and Fas ligand: a death factor and its receptor. Adv. Immunol. 57:129-144.
20. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science (Wash. DC). 267:1449-1456.
21. Suda, T., and S. Nagata. 1994. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:873-879.
22. Vignaux, F., E. Vivier, B. Malissen, V. Depraetere, S. Nagata, and P. Golstein. 1995. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181:781-786.
23. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, D.H. Lynch, C.F. Ware, and D.R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (Lond.). 373:441-444.
24. Dhein, J., H. Walczak, C. Baumler, K. Debatin, and P.H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature (Lond.). 373:438-441.
25. Ju, S., D.J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stranger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature (Lond.). 373:444-448.
26. Alderson, M.R., T.W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K.A. Schooley, R.G. Goodwin, C.A. Smith, F. Ramsdell, and D.H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
27. + T cells responding to a bacterial superantigen. J. Immunol. 154:4302-4308.
28. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T-cell mediated cytotoxity. Science (Wash. DC). 265:528-530.
29. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature (Lond.). 370:650-652.
30. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195-200.
31. + T cell-mediated cytotoxicity. J. Immunol. 152:1127-1133.
32. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO (Eur. Mol. Biol. Organ.) J. 14:1129-1135.
33. Hollenbaugh, D., and S. Arrufo. Construction of immunoglobulin fusion proteins. In Current Protocols in Immunology. Vol. 2. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. John Wiley & Sons, New York. 10.19.1-10.19.11.
34. Linsley, P.S., W. Brady, L. Grosmaire, Alejandro Aruffo, N.K. Damle, and J.A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721-730.
35. Liles, W.C., J.A. Ledbetter, A.W. Waltersdorph, and S.J. Klebanoff. 1995. Cross-linking of CD45 enhances activation of the respiratory burst in response to specific stimuli in human phagocytes. J. Immunol. 155:2175-2184.
36. Park, J.R., K. Robertson, D.D. Hickstein, S. Tsai, D.M. Hockenbery, and S.J. Collins. 1994. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood. 84:440-445.
37. Fadok, V.A., D.R. Voelker, P.A. Campbell, J.J. Cohen, D.L. Bratton, and P.M. Henson. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207-2216.
38. Koopman, G., C.P.M. Reutelingsperger, G.A.M. Kuitjen, R.M.J. Keehnen, S.T. Pals, and M.H.J. van Oers. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1415-1420.
39. Eischen, C.M., C.J. Dick, and P.J. Leibson. 1994. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. 153:1947-1954.
40. Akiyama, T., J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:5592-5595.
41. Kondo, K., T. Watanabe, H. Sasaki, Y. Uehara, and M. Oishi. 1989. Induction of in vitro differentiation of mouse embryonal carcinoma (F9) and erythroleukemia (MEL) cells by hebimycin A, an inhibitor of protein phosphorylation. J. Cell Biol. 109:285-293.
42. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1169-1178.
43. Tanaka, M., T. Suda, K. Haze, N. Nakamura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, et al., 1996. Fas ligand in human serum. Nature Medicine. 2:317-322.
44. El-Hag, A., and R.A. Clark. 1987. Immunosuppression by activated human neutrophils. J. Immunol. 139:2406-2413.
45. + T cells. Nature (Lond.). 376:181-184.
46. Matsumoto, K., R.P. Schleimer, H. Saito, Y. Iikura, and B.S. Bochner. 1995. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood. 86:1437-1443.
47. Gillette-Ferguson, I., and C.L. Sidman. 1994. A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice. Eur. J. Immunol. 24:1181-1185.
48. Vignaux, F., and P. Golstein. 1994. Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur. J. Immunol. 24:923-927.
49. Richardson, B.C., N.D. Lalwani, K.J. Johnson, and R.M. Marks. 1994. Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur. J. Immunol. 24:2640-2645.
50. 2 integrins. Clin. Res. 42:148a.
51. Cifone, M.G., R. De Maria, R. Roncaioli, M.R. Rippo, M. Azuma, L.L. Lanier, A. Santoni, and R. Testi. 1994. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 180:1547-1552.
52. Tepper, C.G., S. Jayadev, B. Liu, A. Bielkawska, R. Wolff, S. Yonehara, Y.A. Hannun, and M.F. Seldin. 1995. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA. 92:8443-8447.
53. 2+ level. J. Immunol. 154: 599-609.
54. Whyte, M.K.B., S.J. Hardwick, L.C. Meagher, J.S. Savill, and C. Haslett. 1993. Transient elevations of cytosolic free calcium retard subsequent apoptosis in neutrophils in vitro. J. Clin. Invest. 92:446-455.
55. Itoh, N., Y. Tsujimoto, and S. Nagata. 1993. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151:621-627.
56. Boise, L.H., M. Gonzalez-Garcia, C.E. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nunez, and C.B. Thompson. 1993. Bcl-x, a bcl-2- related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:597-608.
57. 1 and bcl-2 repress a common pathway of cell death. J. Exp. Med. 182:821-828.
58. Park, J.R., I.D. Bernstein, and D.M. Hockenbery. 1995. Primitive human hematopoietic precursors express bcl-x but not bcl-2. Blood. 86:868-876.
59. Motoyama, N., F. Wang, K.A. Roth, H. Sawa, K. Nakayama, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii, and D.Y. Loh. 1995. Massive cell death of immature hematopoietic cells and neurons in bcl-x-deficient mice. Science (Wash. DC). 267:1506-1510.
60. Malech, H.L., and J.I. Gallin. 1987. Neutrophils in human diseases. N. Engl. J. Med. 317:687-694.